Bank of America (BofA) has raised its estimates on Hims & Hers Health (NYSE: HIMS) stock ahead of the company’s ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hot List Hot List Pro

Hims and Hers (HIMS) PT Raised to $61 at NeedhamFebruary 25, 2025 6:07 AM Leerink Partners Reiterates Market Perform Rating on Hims and Hers (HIMS)February 25, 2025 5:36 AM Morgan Stanley Reiterates Equalweight Rating on Hims and Hers (HIMS)February 25, 2025 5:35 AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)February 25, 2025 5:34 AM BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $21February 25, 2025 5:17 AM BTIG Reiterates Buy Rating on Hims and Hers (HIMS)February 25, 2025 5:11 AM Hims and Hers (HIMS) PT Raised to $27 at Citi, Maintains Sell 'as we await a better entry point and more details on growth outside GLP-1s'February 25, 2025 4:58 AM